Cover Image

Clear cell sarcoma or Malignant melanoma of soft part - a rare entity

SIVAKUMAR M MAHALINGAM

Abstract


Clear cell sarcoma is an extremely rare,
slow growing and aggressive soft tissue
sarcoma with melanocytic differentiation.
We report a case of recurrent clear cell
sarcoma treated at our Institute for its
rarity and need for appropriate diagnosis
and treatment. A 26 year old male presented
to our Institute with recurrent
swelling in the right popliteal fossa for 1
month duration. He had previous excision
of the right popliteal fossa lesion
and reported as alveolar rhabdomyosarcoma
outside and he came to our Institute
for further treatment. On evaluation
he was diagnosed with non-metastatic
recurrent clear cell sarcoma of the right
popliteal fossa. He had right popliteal
fossa exploration and underwent right
above knee amputation in view of popliteal
vessel and nerve involvement. He
had an uneventful recovery and is receiving
ifosfamide and doxorubicin based adjuvant
chemotherapy. Clear cell sarcoma
is a rare melanin producing soft tissue
sarcoma with diagnostic challenge. Complete
surgical excision is
the optimal treatment for local control.
Keyword :Sarcoma, clear cell, melanoma


Full Text:

PDF

References


Enzinger FM. 1965. Clear-Cell

Sarcoma of Tendons and Aponeuroses.

an Analysis of 21

Cases. Cancer 18:1163-74.

E. B. Chung and F. M. Enzinger,

“Malignant melanoma of soft parts.

A reassessment of clear cell sarcoma,”

American Journal of Surgical

Pathology, vol. 7, no. 5, pp. 405

–413, 1983.

A. Ferrari, M. Casanova, G. Bisogno

et al., “Clear cell sarcoma of

tendons and aponeuroses in pediatric

patients: a report from the Italian

and German Soft Tissue Sarcoma

Cooperative Group,” Cancer, vol.

, no. 12, pp. 3269–3276, 2002.

E. A. Montgomery, J. M. Meis, A.

G. Ramos et al. “Clear cell sarcoma

of tendons and aponeu-roses: a

clinicopathologic study of 58 cases

with analysis of prognostic factors,”

International Journal of Surgical Pathology,

vol. 1, pp. 89–100, 1993.

J. J. Eckardt, D. J. Pritchard, and

E. H. Soule, “Clear cell sarcoma. A

clinicopathologic study of 27 cases,”

Cancer, vol. 52, no. 8, pp. 1482–

, 1983.

Sara AS, Evans HL, and Benjamin

RS. 1990. Malignant Melanoma

of Soft Parts (Clear Cell Sarcoma):

A Study of 17 Cases, With Emphasis

on Prognostic Factors. Cancer

:367-374.

Bridge J, Sreekantaiah C, Neff J

et al. 1991. Cytogenetic findings in

clear cell sarcoma of tendons and

aponeuroses.

Malignant melanoma of soft

parts. Cancer genetics and cytogenetics

(1):101-6.

F. Picciotto, A. Zaccagna, G. Derosa et

al., “Clear cell sarcoma (malignant melanoma

of soft parts) and sentinel lymph

node biopsy,” European Journal of Dermatology,

vol. 15, no. 1, pp. 46–48,

Jones RL, Constantinidou A, Thway K

et al. 2010. Chemotherapy in clear cell

sarcoma. Medical oncology:859-863.

EORTC and Pfizer. 2012. Crosstumoral

Phase 2 Clinical Trial Exploring

Crizotinib (PF-02341066) in Patients

With Advanced Tumors Induced by

Causal Alterations of ALK and/or MET

("CREATE"). In: ClinicalTrials.gov

[Internet]. Bethesda (MD): National Library

of Medicine (US).

Liu S, Cheng H, and Kwan W. 2008.

Histone deacetylase inhibitors induce

growth arrest, apoptosis, and differentiation

in clear cell sarcoma models apoptosis,

and differentiation in clear cell sarcoma

models. Molecular Cancer Therapeutics:

-1761.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University